Date: 28th September 2026
Ownership & Market Activity
Details of Transaction:
- Acquiring Entity: Sanofi Healthcare India Private Limited (Member of the Promoter Group)
- PAN: AAECS6982Q
- Address: 2nd Floor, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072
- Selling Entity: Hoechst GmbH (Promoter of the Company)
- Type of Securities: Equity Shares
- Number of Shares Acquired: 3,500,000
- Percentage of Shareholding Acquired: 15.20%
- Transaction Value: ₹10,68,20,00,000 (Indian Rupees One Thousand Sixty Eight Crore Twenty Lakh)
- Transaction Date: 24th September 2026
- Intimation Date to Company: 25th September 2026
- Mode of Acquisition: Inter-se transfer among members of the promoter and promoter group through a block deal mechanism on the stock exchange
- Exchange: The National Stock Exchange of India Limited
- Holding Prior to Acquisition: Nil (0 shares)
- Holding Post Acquisition: 3,500,000 shares (15.20%)
- Note: Value of transaction excludes taxes, brokerage, and any other charges
Signatories and Authentication
Company Submission:
- Submitted by: Haresh Bachubhai Vala, Company Secretary and Compliance Officer of Sanofi India Limited
- Membership No.: A18246
- Submission Date: 28th September 2026
- Digital Signature Timestamp: 2026.09.28 13:00:16 +05'30'
Disclosure Origin:
- Submitted by: Neha Pukhraj Pokhrana, Company Secretary of Sanofi Healthcare India Private Limited
- Membership No.: A40082
- Submission Date: 25th September 2026
- Place: Mumbai
- Digital Signature Timestamp: 2026.09.25 13:39:46 +05'30'
Derivatives Trading
Details: Not Applicable - The disclosure confirms no trading in derivatives on the company's securities was involved in this transaction.